
The chief scientific officer and medical director of Segal Trials shares more on KarXT, a first in class for muscarinic agonists, and what he's excited about at the upcoming 2024 APA Annual Meeting.
Dr Kakar is the chief scientific officer and medical director of Segal Trials, a board-certified psychiatrist, and a principal investigator of over 200 phase I to IV outpatient and inpatient clinical studies.
Published: May 3rd 2024 | Updated: